Links
News, op-eds, and analysis worth a second look.
- Slower Price Growth, Modest Utilization Increases Drove Slowdown In US Health Care Spending Growth, 2014–19 —
- Cleveland Clinic Cancer Institute establishes AI task force —
- OpenAI acquires AI drug development platform —
- The cancer vaccine landscape: What to know —
- 6 healthcare fights on the ballot this midterm election —
- FDA launches new framework for rare disease drugs —
- Iowa sues OpenAI over ChatGPT's 'dangerous medical advice' —
- HHS launches Kidney Care National Plan, aims to grow access to home-based care —
- Trump EO creates new NIH division centered on women’s health —
- Drugmakers, PhRMA seek to join hospitals' 340B rebate lawsuit —
- Prescription Drug Affordability Boards Reshape Reimbursement While Leaving Core Problems Unresolved —
- Insurance-agent group sues over ACA broker-registration freeze —
- Merck CEO: Cancer vaccine production timeline to shorten —
- Industry leaders establish a common framework for provider directory data —
- Individual market enrollment drops 18% —
- No Surprises Act arbitration awards near 6% of commercial medical spend in some regions: UnitedHealthcare —
- Treasury and IRS propose tighter ACA premium-tax-credit eligibility checks —
- Provider-Sponsored Health Plans Negotiated Lower Prices For Health Services Compared With Traditional Insurers, 2024 —
- When Negotiated Prices Become The Benchmark: Prior MFPs And The Vanishing Role Of Value —
- New bill would delay 340B rebate pilot for 2 years: 6 notes —
- The 340B rebate fight escalates: 20 key developments —
- Hospital groups sue to halt revised 340B rebate pilot —
- NIH plans national effort on personalized cancer vaccines —
- PhRMA sues Trump admin to block CMS' international drug pricing model —
- 32 House members urge CMS to rethink remote patient monitoring ban —
- Utah authorizes three additional healthcare AI pilots with staged oversight —
- Several Changes to 340B Slated for 2027 —
- Enhanced Nurse Licensure Compact Associated with More Working Nurses —
- Trump to send $90 payments to 20 million Medicare enrollees —
- Google says new Gemini model found critical flaw in hospital software —
- Final transparency rules standardize insurer price files —
- 5 governors push HHS to delay Medicaid work requirements —
- HOPDs paid 102% more for same drugs —
- Trump sending $500 checks to ACA enrollees —
- CMS finalizes new drug pricing model —
- FDA approves Eli Lilly's weekly insulin injection —
- Section 232 Tariffs on Drugs Take Effect —
- AHA seeks permanent 340B rebate ban: 6 things to know —
- Trump administration seeks to reshore 86 critical drugs —
- Utilization Driving Increased Health Care Spending —
- FDA approves 1st treatment for rare childhood genetic disease —
- Federal judge declines to intervene in Cigna’s refusal to pay $3M No Surprises Act award —
- Novo plans 5+ blockbuster drug launches by 2030: 5 things to know —
- BioNTech says lung cancer drug candidate prolonged lives in trial —
- Trump administration backing off NIH grant order amid pushback —
- All 50 States Apply for CMS's GENEROUS Model, With $64.3B in Savings Projected —
- Census Bureau: Uninsurance rates held steady from 2024-2025 —
- 5 No Surprises Act updates —
- Cancer death rate falls 35% in 10 years: Report —
- AI Is Helping Patients Solve Medical Mysteries —
- Lung disease drug posts record 56.3% reduction in trial: 5 notes —
- More employers are dropping the largest PBMs —
- Costco to enter Medicare Advantage market —
- States Will Soon Face Huge Penalties for Their Food Stamp Mistakes —
- The FDA Should Stick to Safety —
- Of course ACA premiums are rising —
- Graham Platner and the Politics of 'Star Search' —
- Tariff India, and half of America's medicine cabinet could disappear —
- Healthcare fraud in California has made Medi-Cal "fiscally unsustainable" —
- US FDA advisers back Replimune skin cancer drug trial data —
- Medicare Advantage payment debate targets quality ratings —
- The Scientist with 1,000 Patents Fueling a Drug Powerhouse —
- Free-Market Health Reform in Bernie Sanders's Vermont —
- How Science Grantmakers Govern —
- FDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment —
- ACA's Patient Choice Boondoggle Not Aging Well —
- Abolish the NIH —
- Centene urges CMS to cut red tape for Medicaid fraud crackdowns —
- Cigna, extending reach into prescription drugs, acquires major pharmacy used by hospitals —
- Pharmacies are disappearing across Pennsylvania as operators blame a broken payment system —